PTPRC and head and neck squamous cell carcinoma: We obtained the single-cell transcriptome data from ref. (42), in which all viable CD45+ immune cells were measured for matched PBMC samples and primary tumor tissue samples from 18 patients with HPV− and 8 patients with HPV+ immunotherapy treatment–naïve HNSCC.